FAFilipe Alves

Filipe Alves

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Filipe Alves has a total of 12 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Medically Actionable Secondary Findings from Whole-Exome Sequencing (WES) Data in a Sample of 3972 Individuals

    by Mafalda Melo, Mariana Ribeiro, Paulo Filipe Silva, Susana Valente, Filipe Alves, Margarida Venâncio, Jorge Sequeiros, João Parente Freixo, Diana Antunes, Jorge Oliveira

    The application of whole-exome sequencing (WES) for diagnostic purposes has the potential to unravel secondary findings unrelated with the primary reason of testing. Some of those might be of high clinical utility and comprise disease-causing variants in genes, related to life-threatening and clinically actionable diseases. Clarifying the allelic frequencies of such variants in specific populations is a crucial step for the large-scale deployment of genomic medicine. We analysed medically relevant variants in the 81 genes from the American College of Medical Genetics and Genomics (ACMG) v3.2 list of actionable loci, using WES data from a diagnostic laboratory cohort of 3972 persons, tentatively resampled to represent the Portuguese population geographic distribution. We identified medically actionable variants in 6.2% of our cohort, distributed across several disease domains: cardiovascular disorders (3.0%), cancer predisposition (2.0%), miscellaneous disorders (1.1%), and metabolic disorders (0.1%). Additionally, we estimated a frequency of heterozygotes for recessive disease alleles of 11.1%. Overall, our results suggest that medically actionable findings can be identified in approximately 6.2% of persons from our population. This is the first study estimating medically actionable findings in Portugal. These results provide valuable insight for patients, healthcare providers, and policymakers involved in advancing genomic medicine at the national and international level.


  • Open Access

    Medically Actionable Secondary Findings from Whole Exome Sequencing (WES) Data in a Sample of 3,972 Individuals

    by Mafalda Melo, Mariana Ribeiro, Paulo Filipe Silva, Susana Valente, Filipe da Costa Alves, Margarida Venâncio, Jorge Sequeiros, Diana Antunes, João Parente Freixo, Jorge Oliveira

    The application of whole-exome sequencing (WES) for diagnostic purposes has the potential to unravel secondary findings unrelated with the primary reason of testing. Some of those might be of high clinical utility and comprise disease-causing variants in genes, related to lifethreatening and clinically actionable diseases. Clarifying the allelic frequencies of such variants in specific populations is a crucial step for the large-scale deployment of genomic medicine. We analysed medically relevant variants in the 81 genes from the American College of Medical Genetics and Genomics (ACMG) v3.2 list of actionable loci, using WES data from a diagnostic laboratory cohort of 3,972 persons, tentatively resampled to represent the Portuguese population geographic distribution. We identified medically actionable variants in 6.2% of our cohort, distributed across several disease domains: cardiovascular disorders (3.0%), cancer predisposition (2.0%), miscellaneous disorders (1.1%), and metabolic disorders (0.1%). Additionally, we estimated a frequency of heterozygotes for recessive disease alleles of 11.1%. Overall, our results suggest that medically actionable findings can be identified in approximately 6.2% of persons from our population. This is the first study estimating medically actionable findings in Portugal. These results provide valuable insight for patients, healthcare providers, and policymakers involved in advancing genomic medicine at the national and international level.

  • Open Access

    Analysis of Regions of Homozygosity: Revisited Through New Bioinformatic Approaches

    by Susana Valente, Mariana Ribeiro, Jennifer Schnur, Filipe Alves, Nuno Moniz, Dominik Seelow, João Parente Freixo, Paulo Filipe Silva, Jorge Oliveira

    Background: Runs of homozygosity (ROHs), continuous homozygous regions across the genome, are often linked to consanguinity, with their size and frequency reflecting shared parental ancestry. Homozygosity mapping (HM) leverages ROHs to identify genes associated with autosomal recessive diseases. Whole-exome sequencing (WES) improves HM by detecting ROHs and disease-causing variants. Methods: To streamline personalized multigene panel creation, using WES and ROHs, we developed a methodology integrating ROHMMCLI and HomozygosityMapper algorithms, and, optionally, Human Phenotype Ontology (HPO) terms, implemented in a Django Web application. Resorting to a dataset of 12,167 WES, we performed the first ROH profiling of the Portuguese population. Clustering models were applied to predict consanguinity from ROH features. Results: These resources were applied for the genetic characterization of two siblings with epilepsy, myoclonus and dystonia, pinpointing the CSTB gene as disease-causing. Using the 2021 Census population distribution, we created a representative sample (3941 WES) and measured genome-wide autozygosity (FROH). Portalegre, Viseu, Bragança, Madeira, and Vila Real districts presented the highest FROH scores. Multidimensional scaling showed that ROH count and sum were key predictors of consanguinity, achieving a test F1-score of 0.96 with additional features. Conclusions: This study contributes with new bioinformatics tools for ROH analysis in a clinical setting, providing unprecedented population-level ROH data for Portugal.


  • Open Access

    Analysis of Regions of Homozygosity: Revisited Through New Bioinformatic Approaches

    by Susana Valente, Mariana Ribeiro, Jennifer Schnur, Filipe Alves, Nuno Moniz, Dominik Seelow, João Parente Freixo, Paulo Filipe Silva, Jorge Oliveira

    Runs of homozygosity (ROH) are contiguous homozygous segments occurring throughout the genome. ROH's number and size heavily depend upon shared parental ancestry, particularly relevant in the context of parental consanguinity. Homozygosity mapping, a valuable technique for the identification of genes associated with human genetic diseases, is based on the presence of ROH. Next-generation sequencing (NGS) improved this process by allowing simultaneous homozygosity mapping and detection of disease-causing variants. In this work, we present the methodology to automate the creation of personalized multigene panels based on whole-exome sequencing (WES) data using ROH (identified by combining two different algorithms: ROHMMCLI and HomozygosityMapper) and/or Human Phenotype Ontology (HPO) terms, and its integration in a Django Web application. The new resources’ applicability and impact on diagnostics are demonstrated through the genetic characterization of two siblings affected by a recessive disease. Resorting to a sample of 3,941 patients generated in this work, we provide an extensive analysis of ROH at a genomic scale for the first time in the Portuguese population. This work also describes the development of a new classification approach based on ROH features. In summary, this research advances ROH analysis from WES data, emphasizing its diagnostic potential and significance in population genetics’ characterization.